State Street
MXCT icon

State Street’s MaxCyte MXCT Stock Holding History

State Street’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
2,193,470
-164,914
-7% -$154K ﹤0.01% 3374
2025
Q4 		$3.66M Buy
2,358,384
+91,534
+4% +$146K ﹤0.01% 3124
2025
Q3 		$3.58M Buy
2,266,850
+83,947
+4% +$146K ﹤0.01% 3127
2025
Q2 		$4.76M Buy
2,182,903
+37,032
+2% +$89.7K ﹤0.01% 2966
2025
Q1 		$5.86M Buy
2,145,871
+1,649
+0.1% +$6.5K ﹤0.01% 2814
2024
Q4 		$8.92M Sell
2,144,222
-124,913
-6% -$472K ﹤0.01% 2693
2024
Q3 		$8.83M Buy
2,269,135
+111,066
+5% +$468K ﹤0.01% 2678
2024
Q2 		$8.46M Buy
2,158,069
+172,545
+9% +$742K ﹤0.01% 2657
2024
Q1 		$8.32M Buy
1,985,524
+41,527
+2% +$195K ﹤0.01% 2687
2023
Q4 		$9.14M Buy
1,943,997
+103,823
+6% +$404K ﹤0.01% 2647
2023
Q3 		$5.74M Buy
1,840,174
+27,800
+2% +$112K ﹤0.01% 2856
2023
Q2 		$8.32M Buy
1,812,374
+18,225
+1% +$83.8K ﹤0.01% 2738
2023
Q1 		$8.88M Buy
1,794,149
+2,582
+0.1% +$12.7K ﹤0.01% 2737
2022
Q4 		$9.78M Buy
1,791,567
+45,058
+3% +$276K ﹤0.01% 2702
2022
Q3 		$11.4M Buy
1,746,509
+189,814
+12% +$1.06M ﹤0.01% 2629
2022
Q2 		$7.36M Sell
1,556,695
-6,065
-0.4% -$29.9K ﹤0.01% 2890
2022
Q1 		$10.9M Buy
1,562,760
+252,201
+19% +$1.72M ﹤0.01% 2777
2021
Q4 		$13.4M Buy
1,310,559
+1,219,183
+1,334% +$13.1M ﹤0.01% 2742
2021
Q3 		$1.12M Buy
+91,376
New +$1.38M ﹤0.01% 3757

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street's MXCT Position: Q1 2026 in Review

State Street reduced its MaxCyte (MXCT) stake by 7% in Q1 2026, selling an estimated $154K and leaving 2,193,470 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

State Street first reported a position in MXCT in Q3 2021 and has held it in 19 quarters since. The position peaked at $13.4M in Q4 2021. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • State Street held 2,193,470 shares of MaxCyte worth $1.54M as of Q1 2026.
  • State Street sold 164,914 MaxCyte shares in Q1 2026, an estimated $154K.
  • MaxCyte made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3374 holding.
  • State Street first reported a position in MaxCyte in Q3 2021 and has held it in 19 quarters since.
  • State Street's MaxCyte position peaked at $13.4M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.